publication venue for
- Transforming Growth Factor-β: Importance in Long-Term Peritoneal Membrane Changes 2005
- Establishing a core outcome measure for life participation in patients receiving peritoneal dialysis: A Standardised Outcomes in Nephrology–Peritoneal Dialysis consensus workshop report. 42:562-570. 2022
- Quantifying the risk of insertion-related peritoneal dialysis catheter complications following laparoscopic placement: Results from the North American PD Catheter Registry. 40:185-192. 2020
- Home Dialysis is Associated with Lower Costs and Better Survival than other Modalities: A Population-Based Study in Ontario, Canada. 39:553-561. 2019
- Intraperitoneal Calcitriol for Treatment of Severe Hyperparathyroidism in Children with Chronic Kidney Disease: A Therapy Forgotten. 36:688-690. 2016
- Peritoneal Dialysis Catheter Increases Leukocyte Recruitment in the Mouse Parietal Peritoneum Microcirculation and Causes Fibrosis. 36:7-15. 2016
- Genetic Polymorphisms and Peritoneal Membrane Function. 35:517-529. 2015
- ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I – Assessment and Management of Various Cardiovascular Risk Factors. 35:379-387. 2015
- ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II – Management of Various Cardiovascular Complications. 35:388-396. 2015
- Hyponatremia in Peritoneal Dialysis: Epidemiology in a Single Center and Correlation with Clinical and Biochemical Parameters. 34:260-270. 2014
- Impact of Modality Choice on Rates of Hospitalization in Patients Eligible for Both Peritoneal Dialysis and Hemodialysis. 34:41-48. 2014
- Peritoneal Dialysis Patients with Critical Illness: Insurance May be Hard to Come By. 32:7-9. 2012
- The Fluid Study Protocol: A Randomized Controlled Study on the Effects of Bioimpedance Analysis and Vitamin D on Left Ventricular Mass in Peritoneal Dialysis Patients. 31:529-536. 2011
- Attitudes of Caregivers to Management of End-Stage Renal Disease in Infants. 31:459-465. 2011
- The Impact of Treatment Modality on Infection-Related Hospitalization Rates in Peritoneal Dialysis and Hemodialysis Patients. 31:440-449. 2011
- Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011. 31:218-239. 2011
- Prolonged Peritoneal Gene Expression Using a Helper-Dependent Adenovirus. 29:508-516. 2009
- Article Commentary: Heparin and the Peritoneal Membrane. 29:16-19. 2009
- Vascular Endothelial Growth Factor Expression in Peritoneal Mesothelial Cells Undergoing Transdifferentiation. 28:497-504. 2008
- Association between N-Terminal Propeptide B-Type Natriuretic Peptide and Markers of Hypervolemia. 28:308-311. 2008
- Adenovirus-Based Transient Expression Systems for Peritoneal Membrane Research. 26:547-558. 2006
- Impact of Peritoneal Dialysis Dose Guidelines on Clinical Outcomes. 25:95-98. 2005
- Early Morning Blues — a Complication of Icodextrin. 24:197-199. 2004
- Basic Mechanisms and Clinical Implications of Peritoneal Fibrosis. 23:530-541. 2003
- Changes in Peritoneal Dialysis Practices in Canada 1996 – 1999. 23:53-57. 2003
- Colonization-Resistant Antimicrobial-Coated Peritoneal Dialysis Catheters: Evaluation in a Newly Developed Rat Model of Persistent Pseudomonas Aeruginosa Peritonitis. 22:27-31. 2002
- A Chronic Inflammatory Infusion Model of Peritoneal Dialysis in Rats. 21:368-372. 2001
- Use of Intraperitoneal Cefepime as Monotherapy in Treatment of CAPD Peritonitis. 20:232-234. 2000
- Peritoneal Membrane Transport and Hypoalbuminemia: Cause or Effect?. 20:14-18. 2000
- Cardiac Ischemia in the Diabetic Patient with End-Stage Renal Disease. 19:305-308. 1999
- Nih Peritoneal Dialysis Workshop Nutrition Subcommittee: Research Recommendationsa. 17:58-59. 1997
- Nutrition and Adequacy of Dialysis. 17:60-62. 1997
- Outcome Studies in Adequacy of Dialysis. 17:42-45. 1997
- Recommended Clinical Practices for Maximizing Peritoneal Dialysis Clearances. 16:448-456. 1996
- Solute Clearance Approach to Adequacy of Peritoneal Dialysis. 16:457-470. 1996
- Peritonitis in Continuous Ambulatory Peritoneal Dialysis {CAPD): A Multi-Centre Randomized Clinical Trial Comparing the Y Connector Disinfectant System to Standard Systems. 9:159-163. 1989
- Trimethoprim-Sulfamethoxazole Pharmacokinetics during Continuous Ambulatory Peritoneal Dialysis (CAPD). 9:51-55. 1989
- Peritonitis in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients: A Randomized Clinical Trial of Cotrimoxazole Prophylaxis. 8:125-128. 1988
- Quality of Life in End-Stage Renal Disease. 4:20-23. 1984